Weihmann Karl, Schleusener Johannes, Eigentler Thomas K, Ghoreschi Franziska C, Moritz Rose K C, Szyc Lukasz, Dronnik Eduard, Meinke Martina C
Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Magnosco GmbH, Berlin, Germany.
Skin Pharmacol Physiol. 2024;37(4-6):97-103. doi: 10.1159/000542854. Epub 2024 Dec 2.
Dermatofluoroscopy is an optical noninvasive method of melanoma/nevus differentiation that has shown 89% sensitivity and 45% specificity in clinical trials, but long measurement duration hinders clinical use. An intelligent algorithm was developed to shorten the measurement time without compromising its diagnostic accuracy. It uses dermoscopic images of the skin lesions to be measured to select measurement points based on the assessment of color values.
27 patients with a total of 29 lesions suggestive of cutaneous melanoma were included in a clinical study and measured with both methods, conventional dermatofluoroscopy and the newly developed intelligent algorithm. The results were compared to the independent findings of two histopathologists to evaluate diagnostic accuracy and time saved.
There was a median reduction of measurement points from 265 to 158 (40%). Meanwhile, the intelligent algorithm showed a higher diagnostic accuracy than conventional dermatofluoroscopy (area under the curve of 72% vs. 63%).
The intelligent algorithm did not perform inferior to the conventional method while saving 40% of time. However, measurement times remain long compared to other noninvasive methods of diagnosing malignant melanoma. Further studies are needed to evaluate clinical suitability.
Dermatofluoroscopy is an optical noninvasive method of melanoma/nevus differentiation that has shown 89% sensitivity and 45% specificity in clinical trials, but long measurement duration hinders clinical use. An intelligent algorithm was developed to shorten the measurement time without compromising its diagnostic accuracy. It uses dermoscopic images of the skin lesions to be measured to select measurement points based on the assessment of color values.
27 patients with a total of 29 lesions suggestive of cutaneous melanoma were included in a clinical study and measured with both methods, conventional dermatofluoroscopy and the newly developed intelligent algorithm. The results were compared to the independent findings of two histopathologists to evaluate diagnostic accuracy and time saved.
There was a median reduction of measurement points from 265 to 158 (40%). Meanwhile, the intelligent algorithm showed a higher diagnostic accuracy than conventional dermatofluoroscopy (area under the curve of 72% vs. 63%).
The intelligent algorithm did not perform inferior to the conventional method while saving 40% of time. However, measurement times remain long compared to other noninvasive methods of diagnosing malignant melanoma. Further studies are needed to evaluate clinical suitability.
皮肤荧光镜检查是一种用于区分黑色素瘤/痣的光学非侵入性方法,在临床试验中显示出89%的敏感性和45%的特异性,但测量时间长阻碍了其临床应用。开发了一种智能算法,以缩短测量时间而不影响其诊断准确性。该算法利用待测量皮肤病变的皮肤镜图像,通过评估颜色值来选择测量点。
一项临床研究纳入了27例共有29处疑似皮肤黑色素瘤病变的患者,并用传统皮肤荧光镜检查和新开发的智能算法这两种方法进行测量。将结果与两位组织病理学家的独立诊断结果进行比较,以评估诊断准确性和节省的时间。
测量点中位数从265个减少到158个(减少了40%)。同时,智能算法显示出比传统皮肤荧光镜检查更高的诊断准确性(曲线下面积分别为72%和63%)。
智能算法在节省40%时间的同时,表现并不逊于传统方法。然而,与其他诊断恶性黑色素瘤的非侵入性方法相比测量时间仍然较长。需要进一步研究以评估其临床适用性。
皮肤荧光镜检查是一种用于区分黑色素瘤/痣的光学非侵入性方法,在临床试验中显示出89%的敏感性和45%的特异性,但测量时间长阻碍了其临床应用。开发了一种智能算法,以缩短测量时间而不影响其诊断准确性。该算法利用待测量皮肤病变的皮肤镜图像,通过评估颜色值来选择测量点。
一项临床研究纳入了27例共有29处疑似皮肤黑色素瘤病变的患者,并用传统皮肤荧光镜检查和新开发的智能算法这两种方法进行测量。将结果与两位组织病理学家的独立诊断结果进行比较,以评估诊断准确性和节省的时间。
测量点中位数从265个减少到158个(减少了40%)。同时,智能算法显示出比传统皮肤荧光镜检查更高的诊断准确性(曲线下面积分别为72%和63%)。
智能算法在节省40%时间的同时,表现并不逊于传统方法。然而,与其他诊断恶性黑色素瘤的非侵入性方法相比测量时间仍然较长。需要进一步研究以评估其临床适用性。